CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $551,000 | -18.0% | 140,226 | +210.4% | 0.01% | -47.4% |
Q2 2019 | $672,000 | -97.0% | 45,175 | -81.0% | 0.02% | -96.6% |
Q2 2017 | $22,249,000 | +15.4% | 237,631 | -21.5% | 0.55% | +17.9% |
Q1 2017 | $19,272,000 | +136.2% | 302,689 | +64.8% | 0.47% | +168.6% |
Q4 2016 | $8,160,000 | +31.3% | 183,693 | +171.9% | 0.18% | -40.1% |
Q3 2015 | $6,213,000 | – | 67,559 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |